Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapyHANFSTEIN, Benjamin; MÜLLER, Martin C; KREIL, Sebastian et al.Haematologica (Roma). 2011, Vol 96, Num 3, pp 360-366, issn 0390-6078, 7 p.Article

Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinibERNST, Thomas; ERBEN, Philipp; MÜLLER, Martin C et al.Haematologica (Roma). 2008, Vol 93, Num 2, pp 186-192, issn 0390-6078, 7 p.Article

A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinibERNST, Thomas; GRUBER, Franz X; LANGE, Thoralf et al.Haematologica (Roma). 2009, Vol 94, Num 9, pp 1227-1235, issn 0390-6078, 9 p.Article

Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a t315i BCR-ABL mutationNICOLINI, Franck E; HAYETTE, Sandrine; MAHON, Francois-Xavier et al.Haematologica (Roma). 2007, Vol 92, Num 9, pp 1238-1241, issn 0390-6078, 4 p.Article

A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance: sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisisSAKAI, Katsuya; ISHIKAWA, Yuichi; NAOE, Tomoki et al.International journal of hematology. 2011, Vol 93, Num 2, pp 237-242, issn 0925-5710, 6 p.Article

Detection of twelve nucleotides insertion in the BCR-ABL kinase domain in an imatinib-resistant but dasatinib-sensitive patient with bi-phenotypic acute leukemiaHAYETTE, Sandrine; CHABANE, Kaddour; TCHIRKOV, Andrei et al.Haematologica (Roma). 2009, Vol 94, Num 9, pp 1324-1326, issn 0390-6078, 3 p.Article

ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemiaERNST, Thomas; HOFFMANN, Jana; ERBEN, Philipp et al.Haematologica (Roma). 2008, Vol 93, Num 9, pp 1389-1393, issn 0390-6078, 5 p.Article

Diagnosis and management of chronic myeloid leukemia : A survey of american and european practice patternsKANTARJIAN, Hagop M; CORTES, Jorge; GUILHOT, Francois et al.Cancer. 2007, Vol 109, Num 7, pp 1365-1375, issn 0008-543X, 11 p.Article

Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes backVON BUBNOFF, N; PESCHEL, C; DUYSTER, J et al.Leukemia. 2003, Vol 17, Num 5, pp 829-838, issn 0887-6924, 10 p.Article

Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumorsTRAYNOR, Anne M; HEWITT, Maureen; O'DWYER, Peter J et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 2, pp 305-314, issn 0344-5704, 10 p.Article

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients : a retrospective analysis from the French intergroup of CML (Fi(φ)-LMC GROUP)NICOLINI, F. E; CORM, S; FACON, T et al.Leukemia. 2006, Vol 20, Num 6, pp 1061-1066, issn 0887-6924, 6 p.Article

Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia : implications for the biology, management, and therapy of the diseaseVALENT, Peter.British journal of haematology. 2008, Vol 142, Num 3, pp 361-378, issn 0007-1048, 18 p.Article

Drug Resistance and BCR-ABL Kinase Domain Mutations in Philadelphia Chromosome―Positive Acute Lymphoblastic Leukemia From the Imatinib to the Second-Generation Tyrosine Kinase Inhibitor Era: The Main Changes Are in the Type of Mutations, But Not in the Frequency of Mutation InvolvementSOVERINI, Simona; DE BENEDITTIS, Caterina; SICA, Simona et al.Cancer. 2014, Vol 120, Num 7, pp 1002-1009, issn 0008-543X, 8 p.Article

Phase I/II trial of adding semisynthetic homoharringtonine in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response on imatinibMARIN, David; KAEDA, Jaspal S; ANDREASSON, Catharina et al.Cancer. 2005, Vol 103, Num 9, pp 1850-1855, issn 0008-543X, 6 p.Article

Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR-ABL mutationGOTOH, Moritaka; TAUCHI, Tetsuzo; YOSHIZAWA, Seiichiro et al.International journal of hematology. 2010, Vol 91, Num 1, pp 128-131, issn 0925-5710, 4 p.Article